This course is designed specifically as an introduction to the important topic of pharmaceutical microbiology, it will review the impact of microbiology on many aspects of pharmaceutical manufacture ...
T he biotech and pharmaceutical sectors stand at the brink of innovation and strategic transformation. Market momentum continues to build, with the global biotechnology market valued at around $2 ...
A closer look at how robotics is reshaping pharmaceutical manufacturing, from improving quality and compliance to enabling more scalable production, and where the technology is headed next.
When President Donald Trump announced 10% global tariffs in April, the pharma industry remained largely unscathed. However, the president has since threatened to slap additional tariffs on ...
The pharmaceutical supply chain operates on a global and fragile network. Many active pharmaceutical ingredients (APIs) and ...
Define Ventures’ new report provides a clear framework for how enterprise healthcare, particularly Big Pharma, is transitioning from AI exploration to execution. It focuses on core categories, ...
In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions. The days of skepticism surrounding ...
In today’s Pharmaceutical Executive Daily, Antengene and UCB enter a billion-dollar global licensing agreement for a bispecific T-cell engager, Teva signs a $400 million strategic growth capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results